---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037819"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-09-23T23:59:59+00:00"
generated_at: "2026-05-31T02:20:27.237521+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals sets 2024 annual meeting for Nov 25; deadlines for proposals and nominations announced

## Summary
- 2024 annual meeting scheduled for November 25, 2024; record date October 18, 2024.
- Stockholder proposals for inclusion in proxy under Rule 14a-8 must be received by October 3, 2024.
- Nominations and other business outside Rule 14a-8 must be submitted by October 3, 2024.
- Universal proxy rule notices for non-company nominees also due by October 3, 2024.

## SEC filing metadata
- accession: 0001493152-24-037819
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-09-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/0001493152-24-037819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224037819/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037819
- JSON: https://secwatch.observer/filing/0001493152-24-037819.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037819.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.